Association between Vitamin D Status and Risk of Developing Severe COVID-19 Infection: A Meta-Analysis of Observational Studies
et al., Journal of the American College of Nutrition, doi:10.1080/07315724.2021.1951891, Aug 2021
Vitamin D for COVID-19
8th treatment shown to reduce risk in
October 2020, now with p < 0.00000000001 from 126 studies, recognized in 18 countries.
No treatment is 100% effective. Protocols
combine treatments.
6,300+ studies for
210+ treatments. c19early.org
|
Meta analysis of 24 observational studies with 3,637 participants, showing low vitamin D status associated with a higher risk of death and a higher risk of developing severe COVID-19 pneumonia.
19 meta analyses show significant improvements with vitamin D treatment for mortality1-13,
mechanical ventilation1,5,6,11,14-16 ,
ICU admission1,3,5,6,9,11,13-18 ,
hospitalization11,
severity2,4,5,10,19 , and
cases7,18,19 .
Currently there are 126 vitamin D treatment for COVID-19 studies, showing 38% lower mortality [31‑45%], 19% lower ventilation [-3‑36%], 45% lower ICU admission [28‑58%], 19% lower hospitalization [9‑29%], and 17% fewer cases [9‑24%].
1.
Shah et al., Does vitamin D supplementation reduce COVID-19 severity? - a systematic review, QJM: An International Journal of Medicine, doi:10.1093/qjmed/hcac040.
2.
Nikniaz et al., The impact of vitamin D supplementation on mortality rate and clinical outcomes of COVID-19 patients: A systematic review and meta-analysis, Pharmaceutical Sciences, doi:10.34172/PS.2021.13.
3.
Hosseini et al., Effects of Vitamin D Supplementation on COVID-19 Related Outcomes: A Systematic Review and Meta-Analysis, Nutrients, doi:10.3390/nu14102134.
4.
D’Ecclesiis et al., Vitamin D and SARS-CoV2 infection, severity and mortality: A systematic review and meta-analysis, PLOS ONE, doi:10.1371/journal.pone.0268396.
5.
Xie et al., Micronutrient perspective on COVID-19: Umbrella review and reanalysis of meta-analyses, Critical Reviews in Food Science and Nutrition, doi:10.1080/10408398.2023.2174948.
6.
Hariyanto et al., Vitamin D supplementation and Covid‐19 outcomes: A systematic review, meta‐analysis and meta‐regression, Reviews in Medical Virology, doi:10.1002/rmv.2269.
7.
Begum et al., The Role of Vitamin D in COVID-19 Survival and Prevention: A Meta-analysis, Sudan Journal of Medical Sciences, doi:10.18502/sjms.v19i1.15776.
8.
Jamilian et al., The role of vitamin D in outcomes of critical care in COVID-19 patients: Evidence from an umbrella meta-analysis of interventional and observational studies, Public Health Nutrition, doi:10.1017/S1368980024000934.
9.
Sobczak et al., Effect of Vitamin D3 Supplementation on Severe COVID-19: A Meta-Analysis of Randomized Clinical Trials, Nutrients, doi:10.3390/nu16101402.
10.
Petrelli et al., Therapeutic and prognostic role of vitamin D for COVID-19 infection: A systematic review and meta-analysis of 43 observational studies, The Journal of Steroid Biochemistry and Molecular Biology, doi:10.1016/j.jsbmb.2021.105883.
11.
Asla et al., Vitamin D on COVID-19 Patients During the Pandemic, 2022. A Systematic Review and Meta-Analysis, Current Research in Nutrition and Food Science Journal, doi:10.12944/CRNFSJ.11.1.3.
12.
Kow et al., The impact of vitamin D administration on mortality in COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials, Inflammopharmacology, doi:10.1007/s10787-024-01564-2.
13.
Zhang et al., The impact of supplementing vitamin D through different methods on the prognosis of COVID-19 patients: a systematic review and meta-analysis, Frontiers in Nutrition, doi:10.3389/fnut.2024.1441847.
14.
Meng et al., The role of vitamin D in the prevention and treatment of SARS-CoV-2 infection: A meta-analysis of randomized controlled trials, Clinical Nutrition, doi:10.1016/j.clnu.2023.09.008.
15.
Yang et al., Therapeutic effects of vitamin D supplementation on COVID-19 aggravation: a systematic review and meta-analysis of randomized controlled trials, Frontiers in Pharmacology, doi:10.3389/fphar.2024.1367686.
16.
Szarpak et al., Vitamin D supplementation to treat SARS-CoV-2 positive patients. Evidence from meta-analysis, Cardiology Journal, doi:10.5603/CJ.a2021.0122.
17.
Tentolouris et al., The effect of vitamin D supplementation on mortality and intensive care unit admission of COVID-19 patients. A systematic review, meta-analysis and meta-regression, Diabetes/Metabolism Research and Reviews, doi:10.1002/dmrr.3517.
Ben-Eltriki et al., 31 Aug 2021, peer-reviewed, 4 authors.
Association between Vitamin D Status and Risk of Developing Severe COVID-19 Infection: A Meta-Analysis of Observational Studies
Journal of the American Nutrition Association, doi:10.1080/07315724.2021.1951891
Objective: The relationship between 25-hydroxyvitamin D3 (25(OH)D), the surrogate marker for vitamin D 3 , serum concentration and COVID-19 has come to the forefront as a potential pathway to improve COVID-19 outcomes. The current evidence remains unclear on the impact of vitamin D status on the severity and outcomes of COVID-19 infection. To explore possible association between low 25(OH)D levels and risk of developing severe COVID-19 (i.e. need for invasive mechanical ventilation, the length of hospital stay, total deaths). We also aimed to understand the relationship between vitamin D insufficiency and elevated inflammatory and cardiac biomarkers. Methods: We conducted a comprehensive electronic literature search for any original research study published up to March 30, 2021. For the purpose of this review, low vitamin D status was defined as a range of serum total 25(OH)D levels of <10 to <30 ng/ml. Two independent investigators assessed study eligibility, synthesized evidence, analyzed, critically examined, and interpreted herein. Results: Twenty-four observational studies containing 3637 participants were included in the meta-analysis. The mean age of the patients was 61.1 years old; 56% were male. Low vitamin D status was statistically associated with higher risk of death (RR, 1.60 (95% CI, 1.10-2.32), higher risk of developing severe COVID-19 pneumonia (RR: 1.50; 95% CI, 1.10-2.05). COVID-19 patients with low vitamin D levels had a greater prevalence of hypertension and cardiovascular diseases, abnormally high serum troponin and peak D-dimer levels, as well as elevated interleukin-6 and C-reactive protein than those with serum 25(OH)D levels ≥30 ng/ml. Conclusions: In this meta-analysis, we found a potential increased risk of developing severe COVID-19 infection among patients with low vitamin D levels. There are plausible biological mechanisms supporting the role of vitamin D in COVID-19 severity. Randomized controlled trials are needed to test for potential beneficial effects of vitamin D in COVID-19 outcomes.
Disclosure statement The authors declare that they have no conflicts of interest.
References
Abrishami, Dalili, Torbati, Asgari, Arab-Ahmadi et al., Possible association of vitamin D status with lung involvement and outcome in patients with COVID-19: a retrospective study, Eur J Nutr, doi:10.1007/s00394-020-02411-0
Adami, Giollo, Fassio, Benini, Bertoldo et al., Vitamin D and disease severity in coronavirus disease 19 (COVID-19), Reumatismo, doi:10.4081/reumatismo.2020.1333
Angelidi, Belanger, Lorinsky, Karamanis, Chamorro-Pareja et al., Vitamin D status is associated with in-hospital mortality and mechanical ventilation: a cohort of COVID-19 hospitalized patients, Mayo Clin Proc, doi:10.1016/j.mayocp.2021.01.001
Anjum, Examine the association between severe Vitamin D deficiency and mortality in patients with Covid-19, Pak J Med Health Sci
Baeke, Takiishi, Korf, Gysemans, Mathieu, Vitamin D: modulator of the immune system, Curr Opin Pharmacol, doi:10.1016/j.coph.2010.04.001
Bagri, Dahri, Legal, Hospital pharmacists' perceptions and decision-making related to drug-drug interactions, Can J Hosp Pharm
Baktash, Hosack, Patel, Shah, Kandiah et al., Vitamin D status and outcomes for hospitalised older patients with COVID-19, Postgrad Med J
Bassatne, Basbous, Chakhtoura, El Zein, Rahme et al., The link between COVID-19 and vitamin D (VIVID): a systematic review and meta-analysis, Metabolism, doi:10.1016/j.metabol.2021.154753
Beard, Bearden, Striker, Vitamin D and the anti-viral state, J Clin Virol, doi:10.1016/j.jcv.2010.12.006
Bhowmik, Tirtha, Iraganaboina, Eluru, A comprehensive analysis of COVID-19 transmission and mortality rates at the county level in the United States considering socio-demographics, health indicators, mobility trends and health care infrastructure attributes, PLoS One, doi:10.1371/journal.pone.0249133
Carpagnano, Lecce, Quaranta, Zito, Buonamico et al., Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19, J Endocrinol Invest, doi:10.1007/s40618-020-01370-x
Castillo, Costa, Barrios, Díaz, Miranda et al., Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study, J Steroid Biochem Mol Biol, doi:10.1016/j.jsbmb.2020.105751
Cereda, Bogliolo, Klersy, Lobascio, Masi et al., Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital, Clin Nutr, doi:10.1016/j.clnu.2020.10.055
Charoenngam, Shirvani, Reddy, Vodopivec, Apovian et al., Association of vitamin D status with hospital morbidity and mortality in adult hospitalized patients with COVID-19, Endocr Pract
Chen, Zhou, Dong, Qu, Gong et al., Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, doi:10.1016/S0140-6736(20)30211-7
Cheng, Levine, Bell, Mangelsdorf, Russell, Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase, Proc Natl Acad Sci, doi:10.1073/pnas.0402490101
De Las Heras, Gimenez, Ferder, Manucha, Lahera, Implications of oxidative stress and potential role of mitochondrial dysfunction in COVID-19: therapeutic effects of vitamin D, Antioxidants, doi:10.3390/antiox9090897
De Lucena, Da, Santos, De Lima, De et al., Mechanism of inflammatory response in associated comorbidities in COVID-19, Diabetes Metab Syndr, doi:10.1016/j.dsx.2020.05.025
Demir, Demir, Aygun, Vitamin D deficiency is associated with COVID-19 positivity and severity of the disease, J Med Virol, doi:10.1002/jmv.26832
Dong, Mo, Hu, Qi, Jiang et al., Epidemiology of COVID-19 among children in China, Pediatrics, doi:10.1542/peds.2020-0702
Drincic, Fuller, Heaney, Armas, 25-Hydroxyvitamin D response to graded vitamin D 3 supplementation among obese adults, J Clin Endocrinol Metab, doi:10.1210/jc.2012-4103
Ejaz, Alsrhani, Zafar, Javed, Junaid et al., COVID-19 and comorbidities: deleterious impact on infected patients, J Infect Public Health, doi:10.1016/j.jiph.2020.07.014
Garg, Kalra, Mahalle, Defining vitamin D deficiency, using surrogate markers, Indian J Endocrinol Metab, doi:10.4103/2230-8210.117189
Gavioli, Miyashita, Hassaneen, Siau, An evaluation of serum 25-hydroxy vitamin D Levels in patients with COVID-19 in New York City, J Am Coll Nutr
Giustina, Bouillon, Binkley, Sempos, Adler et al., Controversies in vitamin D: a statement from the third international conference, JBMR Plus, doi:10.1002/jbm4.10417
Griffin, Hewison, Hopkin, Kenny, Quinton et al., Preventing vitamin D deficiency during the COVID-19 pandemic: UK definitions of vitamin D sufficiency and recommended supplement dose are set too low, Clin Med (Lond)), doi:10.7861/clinmed.2020-0858
Griffin, Xing, Kumar, Vitamin D and its analogs as regulators of immune activation and antigen presentation, Annu Rev Nutr, doi:10.1146/annurev.nutr.23.011702.073114
Hernandez, Nan, Fernandez-Ayala, Garcia-Unzueta, Hernandez-Hernandez et al., Vitamin D status in hospitalized patients with SARS-CoV-2 infection, J Clin Endocrinol Metab, doi:10.1210/clinem/dgaa733
Holick, Binkley, Bischoff-Ferrari, Gordon, Hanley et al., Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metab, doi:10.1210/jc.2011-0385
Jain, Chaurasia, Sengar, Singh, Mahor et al., Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers, Sci Rep, doi:10.1038/s41598-020-77093-z
Jevalikar, Mithal, Singh, Sharma, Farooqui et al., Lack of association of baseline 25-hydroxyvitamin D levels with disease severity and mortality in Indian patients hospitalized for COVID-19, Sci Rep, doi:10.1038/s41598-021-85809-y
Ji, Zhu, Zhong, Li, Pang et al., Association of elevated inflammatory markers and severe COVID-19: a meta-analysis, Medicine, doi:10.1097/MD.0000000000023315
Karahan, Katkat, Impact of serum 25(OH) vitamin D level on mortality in patients with COVID-19 in Turkey, J Nutr Health Aging, doi:10.1007/s12603-020-1479-0
Kerget, Kerget, Kızıltunç, Koçak, Araz et al., Evaluation of the relationship of serum vitamin D levels in COVID-19 patients with clinical course and prognosis, Tuberk Toraks, doi:10.5578/tt.70027
Levin, Hanage, Owusu-Boaitey, Cochran, Walsh et al., Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications, Eur J Epidemiol, doi:10.1007/s10654-020-00698-1
Liberati, Altman, Tetzlaff, Mulrow, Gøtzsche et al., The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration, BMJ, doi:10.1136/bmj.b2700
Lui, Yip, Wong, Chow, Ho et al., Significantly lower case-fatality ratio of coronavirus disease 2019 (COVID-19) than Severe Acute Respiratory Syndrome (SARS) in Hong Kong-a territory-wide cohort study, Clin Infect Dis, doi:10.1093/cid/ciaa1187
Luo, Liao, Shen, Li, Cheng, Vitamin D deficiency is inversely associated with COVID-19 incidence and disease severity in Chinese people, J Nutr, doi:10.1093/jn/nxaa332
Maghbooli, Sahraian, Ebrahimi, Pazoki, Kafan et al., Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection, PLoS One, doi:10.1371/journal.pone.0239799
Medrano, Carrillo-Cruz, Montero, Perez-Simon, Vitamin D: effect on haematopoiesis and immune system and clinical applications, Int J Mol Sci, doi:10.3390/ijms19092663
Mercola, Grant, Wagner, Evidence regarding vitamin D and risk of COVID-19 and its severity, Nutrients, doi:10.3390/nu12113361
Moher, Liberati, Tetzlaff, Altman, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, BMJ, doi:10.1136/bmj.b2535
Munshi, Hussein, Toraih, Elshazli, Jardak et al., Vitamin D insufficiency as a potential culprit in critical COVID-19 patients, J Med Virol, doi:10.1002/jmv.26360
Naserghandi, Allameh, Saffarpour, All about COVID-19 in brief, New Microbes New Infect, doi:10.1016/j.nmni.2020.100678
Onder, Rezza, Brusaferro, Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy, JAMA, doi:10.1001/jama.2020.4683
Orchard, Baldry, Nasim-Mohi, Monck, Saeed et al., Vitamin D levels and intensive care unit outcomes of a cohort of critically ill COVID-19 patients, Clin Chem Lab Med, doi:10.1515/cclm-2020-1567
Pereira, Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis, Crit Rev Food Sci Nutr, doi:10.1080/10408398.2020.1841090
Pike, Christakos, Biology and mechanisms of action of the vitamin D hormone, Endocrinol Metab Clin North Am, doi:10.1016/j.ecl.2017.07.001
Piotrowska, Wierzbicka, Żmijewski, Vitamin D in the skin physiology and pathology, Acta Biochim Pol, doi:10.18388/abp.2015_1104
Radujkovic, Hippchen, Tiwari-Heckler, Dreher, Boxberger, Vitamin D deficiency and outcome of COVID-19 patients, Nutrients, doi:10.3390/nu12092757
Ricci, Pagliuca, ' Ascanio, Innammorato, Vitis et al., Circulating vitamin D levels status and clinical prognostic indices in COVID-19 patients, Respir Res, doi:10.1186/s12931-021-01666-3
Rosen, Abrams, Aloia, Brannon, Clinton et al., IOM committee members respond to Endocrine Society vitamin D guideline, J Clin Endocrinol Metab, doi:10.1210/jc.2011-2218
Shereen, Khan, Kazmi, Bashir, Siddique, COVID-19 infection: origin, transmission, and characteristics of human coronaviruses, J Adv Res, doi:10.1016/j.jare.2020.03.005
Smet, Smet, Herroelen, Gryspeerdt, Martens, Serum 25(OH)D level on hospital admission associated with COVID-19 stage and mortality, Am J Clin Pathol, doi:10.1093/ajcp/aqaa252
Sreedharan, Nair, Muttappallymyalil, Gopakumar, Eapen et al., Case fatality rates of COVID-19 across the globe: are the current draconian measures justified?, Z Gesundh Wiss, doi:10.1007/s10389-021-01491-4
Stroehlein, Wallqvist, Iannizzi, Mikolajewska, Metzendorf et al., Vitamin D supplementation for the treatment of COVID-19: a living systematic review, Cochrane Database Syst Rev, doi:10.1002/14651858.CD015043
Takeyama, Kitanaka, Sato, Kobori, Yanagisawa et al., 25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis, Science, doi:10.1126/science.277.5333.1827
Tehrani, Khabiri, Moradi, Mosavat, Khabiri, Evaluation of vitamin D levels in COVID-19 patients referred to Labafinejad hospital in Tehran and its relationship with disease severity and mortality, Clin Nutr Espen, doi:10.1016/j.clnesp.2021.01.014
Vassiliou, Jahaj, Pratikaki, Orfanos, Dimopoulou et al., Low 25-hydroxyvitamin D levels on admission to the intensive care unit may predispose COVID-19 pneumonia patients to a higher 28-day mortality risk: a pilot study on a Greek ICU Cohort, Nutrients, doi:10.3390/nu12123773
Volkert, Beck, Cederholm, Goisser, Hooper et al., ESPEN guideline on clinical nutrition and hydration in geriatrics, Clin Nutr, doi:10.1016/j.clnu.2018.05.024
Walker, Deb, Ling, Wang, Assessing the elevation of cardiac biomarkers and the severity of COVID-19 infection: a meta-analysis, J Pharm Pharm Sci, doi:10.18433/jpps31501
White, Vitamin D signaling, infectious diseases, and regulation of innate immunity, Infect Immun, doi:10.1128/IAI.00353-08
Xu, Soruri, Gieseler, Peters, 1,25-Dihydroxyvitamin D3 exerts opposing effects to IL-4 on MHC class-II antigen expression, accessory activity, and phagocytosis of human monoc y t e s . S c a n d J Im mu n, doi:10.1111/j.1365-3083.1993.tb03237.x
Xu, Yang, Chen, Luo, Zhang et al., Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system, Mol Med Rep, doi:10.3892/mmr.2017.7546
Ye, Tang, Liao, Shaw, Deng et al., Does serum vitamin D level affect COVID-19 infection and its severity?-A case-control study, J Am Coll Nutr
DOI record:
{
"DOI": "10.1080/07315724.2021.1951891",
"ISSN": [
"2769-7061",
"2769-707X"
],
"URL": "http://dx.doi.org/10.1080/07315724.2021.1951891",
"alternative-id": [
"10.1080/07315724.2021.1951891"
],
"assertion": [
{
"label": "Peer Review Statement",
"name": "peerreview_statement",
"order": 1,
"value": "The publishing and review policy for this title is described in its Aims & Scope."
},
{
"URL": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=uacn21",
"label": "Aim & Scope",
"name": "aims_and_scope_url",
"order": 2,
"value": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=uacn21"
},
{
"group": {
"label": "Publication History",
"name": "publication_history"
},
"label": "Received",
"name": "received",
"order": 0,
"value": "2021-04-09"
},
{
"group": {
"label": "Publication History",
"name": "publication_history"
},
"label": "Revised",
"name": "revised",
"order": 1,
"value": "2021-07-01"
},
{
"group": {
"label": "Publication History",
"name": "publication_history"
},
"label": "Accepted",
"name": "accepted",
"order": 2,
"value": "2021-07-01"
},
{
"group": {
"label": "Publication History",
"name": "publication_history"
},
"label": "Published",
"name": "published",
"order": 3,
"value": "2021-08-31"
}
],
"author": [
{
"affiliation": [
{
"name": "Cochrane Hypertension Review Group, University of British Columbia, Vancouver, Canada"
},
{
"name": "Therapeutics Initiative, Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, Canada"
}
],
"family": "Ben-Eltriki",
"given": "Mohamed",
"sequence": "first"
},
{
"affiliation": [
{
"name": "Department of Pharmaceutical Sciences, College of Pharmacy, Larkin University, Miami, Florida, USA"
}
],
"family": "Hopefl",
"given": "Robert",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Cochrane Hypertension Review Group, University of British Columbia, Vancouver, Canada"
},
{
"name": "Therapeutics Initiative, Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, Canada"
},
{
"name": "Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada"
}
],
"family": "Wright",
"given": "James M.",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Pharmaceutical Sciences, College of Pharmacy, Larkin University, Miami, Florida, USA"
}
],
"family": "Deb",
"given": "Subrata",
"sequence": "additional"
}
],
"container-title": "Journal of the American Nutrition Association",
"container-title-short": "Journal of the American Nutrition Association",
"content-domain": {
"crossmark-restriction": true,
"domain": [
"www.tandfonline.com"
]
},
"created": {
"date-parts": [
[
2021,
8,
31
]
],
"date-time": "2021-08-31T21:08:16Z",
"timestamp": 1630444096000
},
"deposited": {
"date-parts": [
[
2023,
11,
8
]
],
"date-time": "2023-11-08T02:56:15Z",
"timestamp": 1699412175000
},
"indexed": {
"date-parts": [
[
2024,
4,
20
]
],
"date-time": "2024-04-20T15:51:07Z",
"timestamp": 1713628267157
},
"is-referenced-by-count": 13,
"issue": "7",
"issued": {
"date-parts": [
[
2021,
8,
31
]
]
},
"journal-issue": {
"issue": "7",
"published-print": {
"date-parts": [
[
2022,
10,
3
]
]
}
},
"language": "en",
"link": [
{
"URL": "https://www.tandfonline.com/doi/pdf/10.1080/07315724.2021.1951891",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "301",
"original-title": [],
"page": "679-689",
"prefix": "10.1080",
"published": {
"date-parts": [
[
2021,
8,
31
]
]
},
"published-online": {
"date-parts": [
[
2021,
8,
31
]
]
},
"published-print": {
"date-parts": [
[
2022,
10,
3
]
]
},
"publisher": "Informa UK Limited",
"reference": [
{
"key": "CIT0001",
"unstructured": "World Health Organization (WHO). WHO Coronavirus Disease (COVID-19) Dashboard. 2020. [cited 2020 October 14]; https://covid19.who.int/."
},
{
"DOI": "10.1016/j.nmni.2020.100678",
"doi-asserted-by": "publisher",
"key": "CIT0002"
},
{
"DOI": "10.1016/j.jare.2020.03.005",
"doi-asserted-by": "publisher",
"key": "CIT0003"
},
{
"DOI": "10.1007/s10654-020-00698-1",
"doi-asserted-by": "publisher",
"key": "CIT0004"
},
{
"DOI": "10.1001/jama.2020.4683",
"doi-asserted-by": "publisher",
"key": "CIT0005"
},
{
"DOI": "10.1371/journal.pone.0249133",
"doi-asserted-by": "publisher",
"key": "CIT0006"
},
{
"DOI": "10.1093/cid/ciaa1187",
"doi-asserted-by": "publisher",
"key": "CIT0007"
},
{
"DOI": "10.1007/s10389-021-01491-4",
"doi-asserted-by": "publisher",
"key": "CIT0008"
},
{
"DOI": "10.1016/S0140-6736(20)30211-7",
"doi-asserted-by": "publisher",
"key": "CIT0009"
},
{
"DOI": "10.1016/j.jiph.2020.07.014",
"doi-asserted-by": "publisher",
"key": "CIT0010"
},
{
"DOI": "10.1542/peds.2020-0702",
"doi-asserted-by": "publisher",
"key": "CIT0011"
},
{
"DOI": "10.1016/j.ecl.2017.07.001",
"doi-asserted-by": "publisher",
"key": "CIT0012"
},
{
"DOI": "10.18388/abp.2015_1104",
"doi-asserted-by": "publisher",
"key": "CIT0013"
},
{
"author": "Bagri H",
"first-page": "288",
"issue": "4",
"journal-title": "Can J Hosp Pharm",
"key": "CIT0014",
"volume": "72",
"year": "2019"
},
{
"DOI": "10.1073/pnas.0402490101",
"doi-asserted-by": "publisher",
"key": "CIT0015"
},
{
"DOI": "10.1126/science.277.5333.1827",
"doi-asserted-by": "publisher",
"key": "CIT0016"
},
{
"DOI": "10.4103/2230-8210.117189",
"doi-asserted-by": "publisher",
"key": "CIT0017"
},
{
"DOI": "10.1128/IAI.00353-08",
"doi-asserted-by": "publisher",
"key": "CIT0018"
},
{
"DOI": "10.1146/annurev.nutr.23.011702.073114",
"doi-asserted-by": "publisher",
"key": "CIT0019"
},
{
"DOI": "10.1111/j.1365-3083.1993.tb03237.x",
"doi-asserted-by": "publisher",
"key": "CIT0020"
},
{
"DOI": "10.1016/j.coph.2010.04.001",
"doi-asserted-by": "publisher",
"key": "CIT0021"
},
{
"DOI": "10.18433/jpps31501",
"doi-asserted-by": "publisher",
"key": "CIT0022"
},
{
"DOI": "10.1136/bmj.b2535",
"doi-asserted-by": "publisher",
"key": "CIT0023"
},
{
"DOI": "10.1136/bmj.b2700",
"doi-asserted-by": "publisher",
"key": "CIT0024"
},
{
"DOI": "10.1007/s00394-020-02411-0",
"doi-asserted-by": "publisher",
"key": "CIT0025"
},
{
"DOI": "10.4081/reumatismo.2020.1333",
"doi-asserted-by": "publisher",
"key": "CIT0026"
},
{
"DOI": "10.1016/j.mayocp.2021.01.001",
"doi-asserted-by": "publisher",
"key": "CIT0027"
},
{
"author": "Anjum S.",
"first-page": "1184",
"issue": "3",
"journal-title": "Pak J Med Health Sci",
"key": "CIT0028",
"volume": "14",
"year": "2020"
},
{
"DOI": "10.1136/postgradmedj-2020-138712",
"author": "Baktash V",
"doi-asserted-by": "crossref",
"first-page": "442",
"journal-title": "Postgrad Med J",
"key": "CIT0029",
"volume": "97",
"year": "2021"
},
{
"DOI": "10.1007/s40618-020-01370-x",
"doi-asserted-by": "publisher",
"key": "CIT0030"
},
{
"DOI": "10.1016/j.clnu.2020.10.055",
"doi-asserted-by": "publisher",
"key": "CIT0031"
},
{
"DOI": "10.1016/j.eprac.2021.02.013",
"doi-asserted-by": "publisher",
"key": "CIT0032"
},
{
"DOI": "10.1002/jmv.26832",
"doi-asserted-by": "publisher",
"key": "CIT0033"
},
{
"DOI": "10.1093/ajcp/aqaa252",
"doi-asserted-by": "publisher",
"key": "CIT0034"
},
{
"DOI": "10.1080/07315724.2020.1869626",
"doi-asserted-by": "publisher",
"key": "CIT0035"
},
{
"DOI": "10.1210/clinem/dgaa733",
"doi-asserted-by": "publisher",
"key": "CIT0036"
},
{
"DOI": "10.1038/s41598-021-85809-y",
"doi-asserted-by": "publisher",
"key": "CIT0037"
},
{
"DOI": "10.1007/s12603-020-1479-0",
"doi-asserted-by": "publisher",
"key": "CIT0038"
},
{
"DOI": "10.1093/jn/nxaa332",
"doi-asserted-by": "publisher",
"key": "CIT0039"
},
{
"DOI": "10.1371/journal.pone.0239799",
"doi-asserted-by": "publisher",
"key": "CIT0040"
},
{
"DOI": "10.1515/cclm-2020-1567",
"doi-asserted-by": "publisher",
"key": "CIT0041"
},
{
"DOI": "10.3390/nu12092757",
"doi-asserted-by": "publisher",
"key": "CIT0042"
},
{
"DOI": "10.1186/s12931-021-01666-3",
"doi-asserted-by": "publisher",
"key": "CIT0043"
},
{
"DOI": "10.1016/j.clnesp.2021.01.014",
"doi-asserted-by": "publisher",
"key": "CIT0044"
},
{
"DOI": "10.3390/nu12123773",
"doi-asserted-by": "publisher",
"key": "CIT0045"
},
{
"DOI": "10.1080/07315724.2020.1826005",
"doi-asserted-by": "publisher",
"key": "CIT0046"
},
{
"DOI": "10.5578/tt.70027",
"doi-asserted-by": "publisher",
"key": "CIT0047"
},
{
"DOI": "10.1038/s41598-020-77093-z",
"doi-asserted-by": "publisher",
"key": "CIT0048"
},
{
"DOI": "10.3390/ijms19092663",
"doi-asserted-by": "publisher",
"key": "CIT0049"
},
{
"DOI": "10.1016/j.metabol.2021.154753",
"doi-asserted-by": "publisher",
"key": "CIT0050"
},
{
"DOI": "10.1080/10408398.2020.1841090",
"doi-asserted-by": "publisher",
"key": "CIT0051"
},
{
"DOI": "10.1002/jmv.26360",
"doi-asserted-by": "publisher",
"key": "CIT0052"
},
{
"DOI": "10.3390/nu12113361",
"doi-asserted-by": "publisher",
"key": "CIT0053"
},
{
"DOI": "10.3390/antiox9090897",
"doi-asserted-by": "publisher",
"key": "CIT0054"
},
{
"DOI": "10.1016/j.dsx.2020.05.025",
"doi-asserted-by": "publisher",
"key": "CIT0055"
},
{
"DOI": "10.1016/j.jcv.2010.12.006",
"doi-asserted-by": "publisher",
"key": "CIT0056"
},
{
"DOI": "10.3892/mmr.2017.7546",
"doi-asserted-by": "publisher",
"key": "CIT0057"
},
{
"DOI": "10.1097/MD.0000000000023315",
"doi-asserted-by": "publisher",
"key": "CIT0058"
},
{
"DOI": "10.1002/jbm4.10417",
"doi-asserted-by": "publisher",
"key": "CIT0059"
},
{
"DOI": "10.1210/jc.2011-0385",
"doi-asserted-by": "publisher",
"key": "CIT0060"
},
{
"DOI": "10.1210/jc.2011-2218",
"doi-asserted-by": "publisher",
"key": "CIT0061"
},
{
"key": "CIT0062",
"unstructured": "National Institutes of Health (NIH). Office of Dietary Supplements. Vitamin D Fact Sheet for Health Professionals. 2021. [cited June 15, 2021]. https://ods.od.nih.gov/factsheets/Vitamin%20D-HealthProfessional/."
},
{
"DOI": "10.1016/j.clnu.2018.05.024",
"doi-asserted-by": "publisher",
"key": "CIT0063"
},
{
"author": "National Institute for Health and Care Excellence: Clinical Guidelines",
"key": "CIT0064",
"volume-title": "COVID-19 rapid guideline: vitamin D",
"year": "2020"
},
{
"DOI": "10.7861/clinmed.2020-0858",
"doi-asserted-by": "publisher",
"key": "CIT0065"
},
{
"DOI": "10.1210/jc.2012-4103",
"doi-asserted-by": "publisher",
"key": "CIT0066"
},
{
"DOI": "10.1016/j.jsbmb.2020.105751",
"doi-asserted-by": "publisher",
"key": "CIT0067"
},
{
"DOI": "10.1002/14651858.CD015043",
"doi-asserted-by": "publisher",
"key": "CIT0068"
}
],
"reference-count": 68,
"references-count": 68,
"relation": {},
"resource": {
"primary": {
"URL": "https://www.tandfonline.com/doi/full/10.1080/07315724.2021.1951891"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [],
"subtitle": [],
"title": "Association between Vitamin D Status and Risk of Developing Severe COVID-19 Infection: A Meta-Analysis of Observational Studies",
"type": "journal-article",
"update-policy": "http://dx.doi.org/10.1080/tandf_crossmark_01",
"volume": "41"
}
